Concurrence Rehnquist | ||
Full case name Inwood Laboratories, Inc., et al. v. Ives Laboratories, Inc. Citations 456 U.S. 844 (more)
102 S. Ct. 2182; 72 L. Ed. 2d 606; 1982 U.S. LEXIS 113; 50 U.S.L.W. 4592; 214 U.S.P.Q. (BNA) 1; 34 Fed. R. Serv. 2d (Callaghan) 1101 Majority O'Connor, joined by Burger, Brennan, Blackmun, Powell, Stevens Concurrence White, joined by Marshall | ||
Inwood Laboratories Inc. v. Ives Laboratories, Inc., 456 U.S. 844 (1982), was a United States Supreme Court case in which the Court set forth the standard for analyzing claims of contributory trademark liability, which is one of the two types of secondary liability in trademark law.
Justice Sandra Day O'Connor, writing for the majority, explained that findings, agreeing with the district court's determination: manufacturers of generic drug, which was designed to duplicate appearance of a similar drug marketed by a competitor under a registered trademark, could not be held vicariously liable under Lanham Act for infringement of that trademark by pharmacists who mislabeled generic drugs with competitor's registered trademark.
This case was used in the Tiffany (NJ) Inc. v. eBay Inc. case.